229 related articles for article (PubMed ID: 10648597)
1. The orphan nuclear receptor SHP utilizes conserved LXXLL-related motifs for interactions with ligand-activated estrogen receptors.
Johansson L; Båvner A; Thomsen JS; Färnegårdh M; Gustafsson JA; Treuter E
Mol Cell Biol; 2000 Feb; 20(4):1124-33. PubMed ID: 10648597
[TBL] [Abstract][Full Text] [Related]
2. The orphan nuclear receptor SHP inhibits agonist-dependent transcriptional activity of estrogen receptors ERalpha and ERbeta.
Johansson L; Thomsen JS; Damdimopoulos AE; Spyrou G; Gustafsson JA; Treuter E
J Biol Chem; 1999 Jan; 274(1):345-53. PubMed ID: 9867849
[TBL] [Abstract][Full Text] [Related]
3. Dosage-sensitive sex reversal adrenal hypoplasia congenita critical region on the X chromosome, gene 1 (DAX1) (NR0B1) and small heterodimer partner (SHP) (NR0B2) form homodimers individually, as well as DAX1-SHP heterodimers.
Iyer AK; Zhang YH; McCabe ER
Mol Endocrinol; 2006 Oct; 20(10):2326-42. PubMed ID: 16709599
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of LXXLL-mediated DAX1/SHP-nuclear receptor interaction network and rational design of stapled LXXLL-based peptides to target the specific network profile.
Qian H; He P; Lv F; Wu W
Int J Biol Macromol; 2019 May; 129():13-22. PubMed ID: 30731167
[TBL] [Abstract][Full Text] [Related]
5. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner).
Seol W; Hanstein B; Brown M; Moore DD
Mol Endocrinol; 1998 Oct; 12(10):1551-7. PubMed ID: 9773978
[TBL] [Abstract][Full Text] [Related]
7. Hormone-independent transcriptional activation and coactivator binding by novel orphan nuclear receptor ERR3.
Hong H; Yang L; Stallcup MR
J Biol Chem; 1999 Aug; 274(32):22618-26. PubMed ID: 10428842
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor alpha regulates expression of the orphan receptor small heterodimer partner.
Lai K; Harnish DC; Evans MJ
J Biol Chem; 2003 Sep; 278(38):36418-29. PubMed ID: 12842887
[TBL] [Abstract][Full Text] [Related]
9. Novel receptor interaction and repression domains in the orphan receptor SHP.
Seol W; Chung M; Moore DD
Mol Cell Biol; 1997 Dec; 17(12):7126-31. PubMed ID: 9372944
[TBL] [Abstract][Full Text] [Related]
10. LXXLL motifs and AF-2 domain mediate SHP (NR0B2) homodimerization and DAX1 (NR0B1)-DAX1A heterodimerization.
Iyer AK; Zhang YH; McCabe ER
Mol Genet Metab; 2007; 92(1-2):151-9. PubMed ID: 17686645
[TBL] [Abstract][Full Text] [Related]
11. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.
Chang Cy; Norris JD; Grøn H; Paige LA; Hamilton PT; Kenan DJ; Fowlkes D; McDonnell DP
Mol Cell Biol; 1999 Dec; 19(12):8226-39. PubMed ID: 10567548
[TBL] [Abstract][Full Text] [Related]
12. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
13. Interaction between the androgen receptor and a segment of its corepressor SHP.
Jouravel N; Sablin E; Arnold LA; Guy RK; Fletterick RJ
Acta Crystallogr D Biol Crystallogr; 2007 Nov; 63(Pt 11):1198-200. PubMed ID: 18007036
[TBL] [Abstract][Full Text] [Related]
14. The coactivator LXXLL nuclear receptor recognition motif.
Savkur RS; Burris TP
J Pept Res; 2004 Mar; 63(3):207-12. PubMed ID: 15049832
[TBL] [Abstract][Full Text] [Related]
15. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
[TBL] [Abstract][Full Text] [Related]
16. Unveiling hidden features of orphan nuclear receptors: the case of the small heterodimer partner (SHP).
Macchiarulo A; Rizzo G; Costantino G; Fiorucci S; Pellicciari R
J Mol Graph Model; 2006 Mar; 24(5):362-72. PubMed ID: 16288980
[TBL] [Abstract][Full Text] [Related]
17. Interaction of transcriptional intermediary factor 2 nuclear receptor box peptides with the coactivator binding site of estrogen receptor alpha.
Wärnmark A; Treuter E; Gustafsson JA; Hubbard RE; Brzozowski AM; Pike AC
J Biol Chem; 2002 Jun; 277(24):21862-8. PubMed ID: 11937504
[TBL] [Abstract][Full Text] [Related]
18. Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes.
Bramlett KS; Wu Y; Burris TP
Mol Endocrinol; 2001 Jun; 15(6):909-22. PubMed ID: 11376110
[TBL] [Abstract][Full Text] [Related]
19. Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERRalpha): crystal structure of ERRalpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1alpha.
Kallen J; Schlaeppi JM; Bitsch F; Filipuzzi I; Schilb A; Riou V; Graham A; Strauss A; Geiser M; Fournier B
J Biol Chem; 2004 Nov; 279(47):49330-7. PubMed ID: 15337744
[TBL] [Abstract][Full Text] [Related]
20. AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors.
Henttu PM; Kalkhoven E; Parker MG
Mol Cell Biol; 1997 Apr; 17(4):1832-9. PubMed ID: 9121431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
